Skip to main navigation Skip to search Skip to main content

Monitoring the effects of medications in residential aged care (nursing home) using digital health technologies: insights from the ReMInDAR and ADEPT projects

    Research output: Contribution to journal › Review article › peer-review

    1 Citation (Scopus)

    Abstract

    The adoption of technology, particularly for monitoring the effects of medications in residential aged care (nursing home), has been slow. Ageing populations have led to increased demand for residential aged care globally, resulting in a growing imperative to implement technological solutions to meet the complex healthcare and medication needs of older people in residential aged care. This commentary explores the potential for and the challenges associated with implementing technological interventions within residential aged care to improve monitoring of medication effects. Drawing on insights from two implementation trials, specifically the Reducing Medicine-induced Deterioration and Adverse Reactions and A Digitally Enabled Pharmacist Service to detecT medicine harms in residential aged care, we discuss the unique challenges and opportunities arising from the real-world applications of digital technologies for medication safety in aged care.

    Original languageEnglish
    Article numberafaf019
    Number of pages5
    JournalAge and Ageing
    Volume54
    Issue number3
    DOIs
    Publication statusPublished - Mar 2025

    Keywords

    • adverse drug events
    • digital health
    • drug safety
    • mHealth
    • older people
    • physical activity

    Fingerprint

    Dive into the research topics of 'Monitoring the effects of medications in residential aged care (nursing home) using digital health technologies: insights from the ReMInDAR and ADEPT projects'. Together they form a unique fingerprint.

    Cite this